Why are we doing cardiovascular outcome trials in type 2 diabetes?

被引：1

作者：

Menon, Venu ^{[1
]}

Aggarwal, Bhuvnesh ^{[1
]}

机构：

[1] Cleveland Clin, Inst Heart & Vasc, Cleveland, OH 44195 USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2014年 / 81卷 / 11期

关键词：

PRIMARY PREVENTION; AMERICAN-COLLEGE; GLUCOSE CONTROL; DISEASE; RISK; MORTALITY; MELLITUS; ASPIRIN; REVASCULARIZATION; CHOLESTEROL;

D O I：

10.3949/ccjm.81gr.14005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cardiovascular disease is the leading cause of morbidity and death in people with diabetes mellitus. While worsening hyperglycemia is directly associated with poorer outcomes, studies aiming at euglycemia have failed to show an advantage over modest glucose-lowering strategies. Several diabetes drugs that were approved solely on the basis of their glucose-lowering potential were later shown to increase cardiovascular risk.

引用

页码：665 / 671

页数：7

共 50 条

[1] A review of cardiovascular outcome trials in type 2 diabetes
Cypryk, Katarzyna
Malecki, Piotr
[J]. ENDOKRYNOLOGIA POLSKA, 2018, 69 (04) : 424 - 431
[2] Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trials
Hinnen, Deborah
Kruger, Davida F.
[J]. DIABETES METABOLIC SYNDROME AND OBESITY, 2019, 12 : 447 - 454
[3] Minority underrepresentation in cardiovascular outcome trials for type 2 diabetes
Hoppe, Charis
Kerr, David
[J]. LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (01): : 13 - 13
[4] Cardiovascular outcome trials in type 2 diabetes: A critical analysis
Ashraf, Hamid
Ahmad, Jamal
[J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (01) : 300 - 305
[5] Cardiovascular outcome trials in Type 2 diabetes: food for thought
Chahade, Jadin J.
Kim, Ryekjang
Ussher, John R.
[J]. FUTURE CARDIOLOGY, 2021, 17 (03) : 407 - 410
[6] Cardiovascular outcome trials in type 2 diabetes: A nurse practitioner perspective
Kruger, Davida F.
[J]. JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2018, 30 : S43 - S52
[7] Clinical implications of cardiovascular outcome trials in type2diabetes
Mellbin, L. G.
Wang, A.
Ryden, L.
[J]. HERZ, 2019, 44 (03) : 192 - 202
[8] Type 2 diabetes and the kidney: Insights from cardiovascular outcome trials
Giugliano, Dario
De Nicola, Luca
Maiorino, Maria Ida
Bellastella, Giuseppe
Esposito, Katherine
[J]. DIABETES OBESITY & METABOLISM, 2019, 21 (08): : 1790 - 1800
[9] Cardiovascular risk and the implications for clinical practice of cardiovascular outcome trials in type 2 diabetes
Chilton, Robert J.
Dungan, Kathleen M.
Shubrook, Jay H.
Umpierrez, Guillermo E.
[J]. PRIMARY CARE DIABETES, 2020, 14 (03) : 193 - 212
[10] Cardiovascular outcome trials in diabetes: what have we learnt?
Kirby, Mike
Boon, Nick
[J]. TRENDS IN UROLOGY & MENS HEALTH, 2018, 9 (04) : 7 - 12

← 1 2 3 4 5 →